Tuesday, July 7, 2026
|
TSX:
24,847
▲ 0.44%
|
Gold:
$3,342
▼ 0.19%
|
BTC:
$108,240
▲ 1.82%
Newsletter
Advertise
About
Boreal
Markets
Canadian Financial Intelligence
Markets
Biotech
Commodities
Resources & Mining
AI & Technology
Bitcoin & Crypto
Small Caps
Videos
Opinion
Subscribe Free
Live
TSX
24,847
▲ +0.44%
S&P 500
5,612
▲ +0.31%
Gold
$3,342
▼ −0.19%
BTC
$108,240
▲ 1.82%
WTI
$78.40
▲ +1.12%
USD/CAD
1.3612
▼ −0.08%
Silver
$33.80
▲ +0.62%
Uranium
$92.50
▲ +2.44%
TSX
24,847
▲ +0.44%
S&P 500
5,612
▲ +0.31%
Gold
$3,342
▼ −0.19%
BTC
$108,240
▲ 1.82%
WTI
$78.40
▲ +1.12%
USD/CAD
1.3612
▼ −0.08%
Silver
$33.80
▲ +0.62%
Uranium
$92.50
▲ +2.44%
Biotech
Biotech
🪙
Biotech
AI Diagnostic Tools Are Hitting Canadian Hospitals at Scale A $340M Adoption Wave
Author
·
July 4, 2026
🔶
Biotech
Canada’s $200M Genomics Strategy: How Federal Investment Is Reshaping Precision Medicine
Author
·
🧬
Biotech
Q3 2026 Canadian Biotech Catalyst Calendar: 14 Data Readouts to Watch
Author
·
July 3, 2026
🔶
Biotech
Robotic Surgery Is Reshaping Canada’s OR A $340M Procurement Wave Is Underway
Author
·
💻
Biotech
Genome Canada’s AI Platform Cuts Variant Interpretation Time From 3 Weeks to 4 Hours
Author
·
⚛️
Biotech
Health Canada Grants 14 Drug Authorizations in Q2 2026 A Record Quarter
Author
·
🧬
Biotech
AbCellera’s AI Antibody Platform Has Now Discovered 120 Drug Candidates. Here’s the Scorecard.
Author
·
July 2, 2026
💰
Biotech
CRISPR Therapeutics Is Selecting Canadian Sites for Its Sickle Cell and Beta-Thalassemia Programs
Author
·
💻
Biotech
Wearable Cardiac Monitors Get Health Canada Class II Clearance Expanding a $420M Market
Author
·
🏦
Biotech
Zymeworks Enters Phase 3 With Bispecific Antibody in HER2+ Gastric Cancer
Author
·
Posts pagination
1
2
3
Older →
The Boreal Brief
Canadian markets intelligence delivered every morning before the open. Free.
Subscribe Free